251 related articles for article (PubMed ID: 33866126)
1. Efficacy of oral perampanel in status epilepticus and acute repetitive seizures in children at a tertiary care hospital in Thailand.
Wachiropathum P; Nabangchang C; Likasitthananon N; Suwanpakdee P
Epilepsy Behav; 2021 May; 118():107964. PubMed ID: 33866126
[TBL] [Abstract][Full Text] [Related]
2. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E
Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657
[TBL] [Abstract][Full Text] [Related]
3. Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures.
Khongkhatithum C; Thampratankul L; Wiwattanadittakul N; Visudtibhan A
Eur J Paediatr Neurol; 2015 Jul; 19(4):429-34. PubMed ID: 25800343
[TBL] [Abstract][Full Text] [Related]
4. Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.
Strzelczyk A; Knake S; Kälviäinen R; Santamarina E; Toledo M; Willig S; Rohracher A; Trinka E; Rosenow F
Acta Neurol Scand; 2019 Apr; 139(4):369-376. PubMed ID: 30613951
[TBL] [Abstract][Full Text] [Related]
5. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
McTague A; Kneen R; Kumar R; Spinty S; Appleton R
Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
Besli GE; Yuksel Karatoprak E; Yilmaz S
Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655
[TBL] [Abstract][Full Text] [Related]
7. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: A single-center audit of 30 patients.
Rohracher A; Kalss G; Neuray C; Höfler J; Dobesberger J; Kuchukhidze G; Kreidenhuber R; Florea C; Thomschewski A; Novak HF; Pilz G; Leitinger M; Trinka E
Epilepsia; 2018 Oct; 59 Suppl 2():234-242. PubMed ID: 30043411
[TBL] [Abstract][Full Text] [Related]
8. Epileptic Status in a PEDiatric cohort (ESPED) requiring intensive care treatment: A multicenter, national, two-year prospective surveillance study.
Meyer S; Langer J; Poryo M; Bay JG; Wagenpfeil S; Heinrich B; Nunold H; Strzelczyk A; Ebrahimi-Fakhari D
Epilepsia Open; 2023 Jun; 8(2):411-424. PubMed ID: 36764666
[TBL] [Abstract][Full Text] [Related]
9. Perampanel Treatment for Refractory Status Epilepticus in a Neurological Intensive Care Unit.
Ho CJ; Lin CH; Lu YT; Shih FY; Hsu CW; Tsai WC; Tsai MH
Neurocrit Care; 2019 Aug; 31(1):24-29. PubMed ID: 30891695
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of perampanel in refractory and super-refractory status epilepticus: cohort study of 81 patients and literature review.
Lim SN; Wu T; Tseng WJ; Chiang HI; Cheng MY; Lin WR; Lin CN
J Neurol; 2021 Oct; 268(10):3744-3757. PubMed ID: 33754209
[TBL] [Abstract][Full Text] [Related]
11. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study.
Winter Y; Sandner K; Vieth T; Gonzalez-Escamilla G; Stuckrad-Barre SV; Groppa S
CNS Drugs; 2023 Oct; 37(10):929-936. PubMed ID: 37784006
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R
Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study.
Beretta S; Padovano G; Stabile A; Coppo A; Bogliun G; Avalli L; Ferrarese C
Epilepsia; 2018 Oct; 59 Suppl 2():243-248. PubMed ID: 30159874
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
[TBL] [Abstract][Full Text] [Related]
15. Perampanel but Not Amantadine Prevents Behavioral Alterations and Epileptogenesis in Pilocarpine Rat Model of Status Epilepticus.
Mohammad H; Sekar S; Wei Z; Moien-Afshari F; Taghibiglou C
Mol Neurobiol; 2019 Apr; 56(4):2508-2523. PubMed ID: 30039334
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures.
Yu KT; Mills S; Thompson N; Cunanan C
Epilepsia; 2003 May; 44(5):724-6. PubMed ID: 12752474
[TBL] [Abstract][Full Text] [Related]
17. Nonintravenous midazolam versus intravenous or rectal diazepam for the treatment of early status epilepticus: A systematic review with meta-analysis.
Brigo F; Nardone R; Tezzon F; Trinka E
Epilepsy Behav; 2015 Aug; 49():325-36. PubMed ID: 25817929
[TBL] [Abstract][Full Text] [Related]
18. Open-label study to investigate the safety and efficacy of adjunctive perampanel in pediatric patients (4 to <12 years) with inadequately controlled focal seizures or generalized tonic-clonic seizures.
Fogarasi A; Flamini R; Milh M; Phillips S; Yoshitomi S; Patten A; Takase T; Laurenza A; Ngo LY
Epilepsia; 2020 Jan; 61(1):125-137. PubMed ID: 31912493
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Adverse Effect of Intravenous Lacosamide in Nonconvulsive Status Epilepticus and Acute Repetitive Seizures in Children.
Ngampoopun M; Suwanpakdee P; Jaisupa N; Nabangchang C
Neurol Res Int; 2018; 2018():8432859. PubMed ID: 29984000
[TBL] [Abstract][Full Text] [Related]
20. Use of perampanel oral suspension for the treatment of refractory and super-refractory status epilepticus.
Bruschi G; Pellegrino L; Bisogno AL; Ferreri F; Kassabian B; Seppi D; Favaretto S; Corbetta M; Dainese F
Epilepsy Behav; 2024 Jul; 156():109826. PubMed ID: 38761446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
